MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway
2019 · Biomedicine & Pharmacotherapy · 46 citations
https://doi.org/10.1016/j.biopha.2019.109111
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
221
Citations
9
h-index
8
i10-index
Weiwei Wan is an academic researcher from Zunyi Medical University. The author has contributed to research in topics: Retinal Diseases and Treatments & MicroRNA in disease regulation & Pancreatic and Hepatic Oncology Research. The author has an h-index of 9, co-authored 12 publications.
ORCID: 0000-0002-3553-5481https://doi.org/10.1016/j.biopha.2019.109111
https://doi.org/10.1186/s13256-025-05630-3
Click to start Chat